This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6–LYN gene fusion
Blood Cancer Journal Open Access 08 April 2016
-
Functions of the Lyn tyrosine kinase in health and disease
Cell Communication and Signaling Open Access 17 July 2012
-
Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms
Blood Cancer Journal Open Access 22 July 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779–1790.
Wernig G, Mercher T, Okabe R, Levine RL, Lee BH, Gilliland DG . Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood 2006; 107: 4274–4281.
Bohlander SK . ETV6: a versatile player in leukemogenesis. Semin Cancer Biol 2005; 15: 162–174.
Xu Y, Harder KW, Huntington ND, Hibbs ML, Tarlinton DM . Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 2005; 22: 9–18.
Donato NJ, Wu JY, Stapley J, Gallick G, Lin H, Arlinghaus R et al. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood 2003; 101: 690–698.
Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 2004; 21: 843–851.
Abe A, Emi N, Kanie T, Imagama S, Kuno Y, Takahashi M et al. Expression cloning of oligomerization-activated genes with cell-proliferating potency by pseudotype retrovirus vector. Biochem Biophys Res Commun 2004; 320: 920–926.
Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM . Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells. Nat Med 2004; 10: 1187–1189.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanaka, H., Takeuchi, M., Takeda, Y. et al. Identification of a novel TEL–Lyn fusion gene in primary myelofibrosis. Leukemia 24, 197–200 (2010). https://doi.org/10.1038/leu.2009.167
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.167
This article is cited by
-
Leukemic cells expressing NCOR1-LYN are sensitive to dasatinib in vivo in a patient-derived xenograft mouse model
Leukemia (2021)
-
Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6–LYN gene fusion
Blood Cancer Journal (2016)
-
Functions of the Lyn tyrosine kinase in health and disease
Cell Communication and Signaling (2012)
-
Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms
Blood Cancer Journal (2011)